Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Nephros (NEPH) Non-Current Debt (2016 - 2022)

Nephros has reported Non-Current Debt over the past 7 years, most recently at $100000.0 for Q4 2022.

  • Quarterly results put Non-Current Debt at $100000.0 for Q4 2022, up 5.26% from a year ago — trailing twelve months through Dec 2022 was $100000.0 (up 5.26% YoY), and the annual figure for FY2022 was $100000.0, up 5.26%.
  • Non-Current Debt for Q4 2022 was $100000.0 at Nephros, down from $200000.0 in the prior quarter.
  • Over the last five years, Non-Current Debt for NEPH hit a ceiling of $1.0 million in Q1 2018 and a floor of $24000.0 in Q1 2022.
  • Median Non-Current Debt over the past 5 years was $482000.0 (2020), compared with a mean of $473000.0.
  • Biggest five-year swings in Non-Current Debt: rose 16.31% in 2021 and later tumbled 91.97% in 2022.
  • Nephros' Non-Current Debt stood at $843000.0 in 2018, then dropped by 27.28% to $613000.0 in 2019, then fell by 21.37% to $482000.0 in 2020, then plummeted by 80.29% to $95000.0 in 2021, then rose by 5.26% to $100000.0 in 2022.
  • The last three reported values for Non-Current Debt were $100000.0 (Q4 2022), $200000.0 (Q2 2022), and $24000.0 (Q1 2022) per Business Quant data.